Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ThaiDoxyPEP
NCT07397403Phase 4Recruiting
- Sponsor
- Bangrak STIs Center
- Start
- Oct 2025
- Primary completion
- Oct 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of doxycycline in syphilis, gonorrhea, Chlamydia trachomatis infection (CT), sponsored by Bangrak STIs Center. Started Oct 2025; status: recruiting.
02
Drugs
doxycycline
03
Conditions
syphilisgonorrheaChlamydia trachomatis infection (CT)
Beyond the preview
Go deeper on NCT07397403.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07397403.